Chiu A G, Newkirk K A, Davidson B J, Burningham A R, Krowiak E J, Deeb Z E
Department of Otolaryngology-Head and Neck Surgery, Georgetown University Medical Center, Washington, DC 20007, USA.
Ann Otol Rhinol Laryngol. 2001 Sep;110(9):834-40. doi: 10.1177/000348940111000906.
Angioedema is a nonpitting edema of which the presentation ranges from benign facial swelling to airway obstruction managed by intubation or tracheotomy. The presentation of this disease is reviewed, and a treatment algorithm based on initial signs and symptoms is proposed for proper airway management. We performed a retrospective review of 108 patients treated in 2 tertiary care centers in the Washington, DC, area over a 5-year period. Ninety-eight patients (90.7%) were African-American, and 81 (75%) were female. Seventy-four patients (68.5%) were taking angiotensin-converting enzyme inhibitors (ACEIs). A classification system was developed based on the location of the edema at initial presentation: 1) isolated facial swelling and oral cavity edema, excluding the floor of the mouth; 2) floor of mouth and/or oropharyngeal edema, and 3) oropharyngeal edema with glottic and/or supraglottic involvement. Fourteen patients (13%) needed airway intervention, 2 of whom underwent a cricothyrotomy after a failed intubation attempt. Eleven (78.6%) were taking ACEIs. The indication for each intubation was massive tongue and floor of mouth edema. The patients were extubated 48 to 72 hours later. No patient demonstrated symptom progression after medical treatment was initiated. Therapy included discontinuation of the ACEI or other inciting agent, a high-humidity face tent, an initial dose of intravenous antihistamines, and a continued course of intravenous steroids. Within 48 hours, most patients had a resolution of their edema. Only cases of significant tongue and oropharyngeal edema took longer than 48 hours to resolve. The ACEIs are a common cause of angioedema. Left untreated, angioedema may progress to involve the oropharynx and supraglottis, resulting in a life-threatening airway compromise. Marked floor of mouth and tongue edema are the indications for airway intervention. An algorithm based on the initial presentation is essential for proper airway and patient management. Once treatment has begun, angioedema is nonprogressive and often resolves within 24 to 48 hours.
血管性水肿是一种非凹陷性水肿,其表现范围从良性面部肿胀到需要通过插管或气管切开术处理的气道梗阻。本文对该疾病的表现进行了综述,并提出了一种基于初始体征和症状的治疗算法,以进行恰当的气道管理。我们对华盛顿特区地区2家三级医疗中心在5年期间治疗的108例患者进行了回顾性研究。98例患者(90.7%)为非裔美国人,81例(75%)为女性。74例患者(68.5%)正在服用血管紧张素转换酶抑制剂(ACEI)。根据初始表现时水肿的部位制定了一个分类系统:1)孤立的面部肿胀和口腔水肿,不包括口底;2)口底和/或口咽水肿,以及3)伴有声门和/或声门上受累的口咽水肿。14例患者(13%)需要气道干预,其中2例在插管尝试失败后接受了环甲膜切开术。11例(78.6%)正在服用ACEI。每次插管的指征均为巨大舌体和口底水肿。患者在48至72小时后拔管。开始药物治疗后,没有患者出现症状进展。治疗措施包括停用ACEI或其他诱发药物、使用高湿度面罩、静脉注射抗组胺药的初始剂量以及持续静脉注射类固醇。48小时内,大多数患者的水肿消退。只有严重的舌体和口咽水肿病例消退时间超过48小时。ACEI是血管性水肿的常见病因。若不治疗,血管性水肿可能进展至累及口咽和声门上区,导致危及生命的气道梗阻。明显的口底和舌体水肿是气道干预的指征。基于初始表现的算法对于恰当的气道和患者管理至关重要。一旦开始治疗,血管性水肿不会进展,且通常在24至48小时内消退。